BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35230578)

  • 1. Chemoprevention for Colorectal Cancers: Are Chemopreventive Effects Different Between Left and Right Sided Colorectal Cancers?
    Arai J; Suzuki N; Niikura R; Ooki D; Kawahara T; Honda T; Hasatani K; Yoshida N; Nishida T; Sumiyoshi T; Kiyotoki S; Ikeya T; Arai M; Ishibashi R; Aoki T; Tsuji Y; Yamamichi N; Hayakawa Y; Fujishiro M
    Dig Dis Sci; 2022 Nov; 67(11):5227-5238. PubMed ID: 35230578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives.
    Mohammed A; Yarla NS; Madka V; Rao CV
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30096840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of colorectal cancer: feasibility in everyday practice?
    Herszényi L; Farinati F; Miheller P; Tulassay Z
    Eur J Cancer Prev; 2008 Nov; 17(6):502-14. PubMed ID: 18941372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colon cancer: preventive agents and the present status of chemoprevention.
    Half E; Arber N
    Expert Opin Pharmacother; 2009 Feb; 10(2):211-9. PubMed ID: 19236194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of colorectal cancer: Past, present, and future.
    Umezawa S; Higurashi T; Komiya Y; Arimoto J; Horita N; Kaneko T; Iwasaki M; Nakagama H; Nakajima A
    Cancer Sci; 2019 Oct; 110(10):3018-3026. PubMed ID: 31361372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study.
    Vinogradova Y; Hippisley-Cox J; Coupland C; Logan RF
    Gastroenterology; 2007 Aug; 133(2):393-402. PubMed ID: 17681160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of Oesophageal Squamous-Cell Carcinoma and Adenocarcinoma: A Multicentre Retrospective Cohort Study.
    Arai J; Niikura R; Hayakawa Y; Kawahara T; Honda T; Hasatani K; Yoshida N; Nishida T; Sumiyoshi T; Kiyotoki S; Ikeya T; Arai M; Suzuki N; Tsuji Y; Yamada A; Kawai T; Koike K
    Digestion; 2022; 103(3):192-204. PubMed ID: 34929693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Aspirin, Vitamin D, Exercise, Diet, Statins, and Metformin in the Prevention and Treatment of Colorectal Cancer.
    Sehdev A; O'Neil BH
    Curr Treat Options Oncol; 2015 Sep; 16(9):43. PubMed ID: 26187794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?
    Manzano A; Pérez-Segura P
    ScientificWorldJournal; 2012; 2012():327341. PubMed ID: 22649288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention.
    Fajardo AM; Piazza GA
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(2):G59-70. PubMed ID: 26021807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of colorectal cancer: ready for routine use?
    Arber N; Levin B
    Recent Results Cancer Res; 2005; 166():213-30. PubMed ID: 15648192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of Colorectal Cancer.
    Katona BW; Weiss JM
    Gastroenterology; 2020 Jan; 158(2):368-388. PubMed ID: 31563626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase as a target for colorectal cancer chemoprevention.
    Moreira L; Castells A
    Curr Drug Targets; 2011 Dec; 12(13):1888-94. PubMed ID: 21158711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of colorectal cancer.
    Das D; Arber N; Jankowski JA
    Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of colorectal neoplasia.
    Wakeman C; Keenan J; Eteuati J; Hollington P; Eglinton T; Frizelle F
    ANZ J Surg; 2017 Dec; 87(12):E228-E232. PubMed ID: 26686322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial.
    Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
    BMC Cancer; 2020 Oct; 20(1):1043. PubMed ID: 33121471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.
    Rostom A; Dubé C; Lewin G; Tsertsvadze A; Barrowman N; Code C; Sampson M; Moher D;
    Ann Intern Med; 2007 Mar; 146(5):376-89. PubMed ID: 17339623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer anatomic distribution patterns remain the same after sessile serrated adenoma/polyp considered cancer precursor: a 9-year comparison study from community-based endoscopy centers.
    Yang JF; Noffsinger AE; Agrawal D; Yang QH
    J Gastrointest Oncol; 2016 Dec; 7(6):917-923. PubMed ID: 28078114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention.
    Xiao H; Yang CS
    Int J Cancer; 2008 Sep; 123(5):983-90. PubMed ID: 18548583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.